Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer

Clinical trial NCT07068542 · RECRUITING

Trial details

NCT number: NCT07068542
Sponsor: Zhejiang Provincial People's Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Advanced Thyroid Carcinoma Radioiodine-refractory Differentiated Thyroid Cancer Poorly Differentiated Thyroid Carcinoma

Start date: 2025-07-01
Primary completion: 2027-12-31
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.